Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
18- 5d agoOvernight26.10.20 09:204Ownership#●●●
Iambic Therapeutics, Inc.
Entities affiliated with Catalio Capital Management, an insider and major shareholder of Iambic Therapeutics, filed a Form 4 regarding changes in their beneficial ownership as of October 16, 2026. This filing details the shift in equity holdings among these investment entities, which investors should monitor.…more
$14.30+0.49%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 08:534Ownership
Iambic Therapeutics, Inc.
Insider R. Jacob Vogelstein of Iambic Therapeutics, Inc. reported a change in his beneficial ownership of securities effective October 16, 2026. This filing serves as an official notification to the SEC regarding the insider's equity transaction.…more
$14.30+0.49%vs prev closeView filingShare - 5d agoAfter-hours26.10.20 08:514Ownership
Iambic Therapeutics, Inc.
Insider Michael Secora of Iambic Therapeutics, Inc. filed a Form 4 on October 19, 2026, reporting changes in beneficial ownership of securities as of October 16, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
$14.30+0.49%vs prev closeView filingShare
17 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoRegular26.10.20 03:19#●●●
Iambic Therapeutics shares trade lower amid post-IPO volatility
Iambic Therapeutics is experiencing downward pressure and price volatility following its recent IPO. Investors should remain cautious as the stock undergoes typical post-listing price discovery.…more
$14.30+0.49%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.15Regular26.10.15 23:10
●●●●●●●● ●●●●● ●●●●●●
The trading halt for the newly listed security has been lifted, allowing normal market activity to resume. Investors can now view real-time quotes and participate in trading for this stock.…more
$14.30+0.49%vs prev closeShareBenzinga - 10.15Overnight26.10.15 16:12
●●●●●●●● ●●●●● ●●●●●●
Iambic has priced its initial public offering of 9.375 million shares at $16.00 per share, aiming to raise $150 million in gross proceeds. The issuance of new shares may lead to dilution for existing shareholders.…more
$14.30+0.49%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report